FYI, not SFRX. Micah runs EXPL. I see why it's in the

New Post Public Reply Private Reply Replies (1) Message Board
Coat Tail Rider
309
FYI, not SFRX. Micah runs EXPL. I see why it's in the tank.

Quote:
Jury Finds Broker-Dealer, Transfer Agent and Two Key Principals Liable in Microcap Shell Factory Fraud

Litigation Release No. 25156 / August 4, 2021

Securities and Exchange Commission v. Spartan Securities Group, Ltd., et al., No. 19-civ-00448 (M.D. Fla. filed February 20, 2019)

On Friday, July 30th, after a three week trial in Federal Court in Tampa, Florida, a jury returned a unanimous verdict finding broker-dealer Spartan Securities Group, LTD., transfer agent, Island Capital Management LLC d/b/a Island Stock Transfer, and two of their principals, Carl E. Dilley and Micah J. Eldred, liable for fraud in connection with their roles in the creation of at least 19 purportedly legitimate public companies that were in fact shams.

Evidence at trial showed that Spartan Securities, Dilley, and Eldred made misrepresentations and omissions in the filing of 15c2-11 applications and submissions with Financial Industry Regulatory Authority (FINRA), which are required to publicly list the companies' common stock and ultimately enable the shares to become free-trading and available to public investors. The evidence also showed that Island Stock Transfer and Dilley, its President, made misrepresentations and omissions regarding the designation of the securities as free trading and when effectuating the bulk issuance and transfer of securities, including stock certificates without restrictive legends. Finally, the evidence revealed that Spartan Securities, Island Stock Transfer, and Dilley initiated and provided false information for applications filed with the Depository Trust Company (DTC), including misrepresenting the shell status of issuers.

The jury found Spartan Securities, Island Stock Transfer, Dilley and Eldred liable for fraud by violating Section 10(b) of the Securities Exchange Act of 1934 ("Exchange Act", and Rule 10b-5(b) thereunder. The jury found Spartan not liable for violating Section 15(c)(2) of the Exchange Act and Rule 15c2-11 thereunder and found Dilley, Eldred and defendant David D. Lopez not liable for aiding and abetting those alleged violations. The jury also found Spartan, Island, Dilley and Eldred not liable for violating or aiding and abetting alleged violations of Section 17(a) of the Securities Act of 1933 ("Securities Act" and Rules 10b-5(a) and (c) of the Exchange Act, and not liable for violating Sections 5(a) and 5(c) of the Securities Act.

The Court will determine the remedies to be imposed against Spartan Securities, Island Stock Transfer, Dilley and Eldred in further proceedings. The SEC seeks permanent injunctions and civil penalties against Spartan Securities, Island Stock Transfer, Dilley, and Eldred; penny stock bars against Spartan Securities, Dilley, and Eldred; and disgorgement of ill-gotten gains with prejudgment interest against Island Stock Transfer.

The SEC's litigation is being conducted by Christine Nestor, Alice Sum, Alise Johnson, and supervised by Andrew Schiff of the Miami Regional Office. The investigation that led to the SEC's action was conducted by Jeffrey Cook and supervised by Eric Busto and Glenn Gordon, also of the Miami Regional office.

Seafarer Exploration (SFRX) Stock Research Links

SFRX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 124

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 90

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 110

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 205

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 162

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 202

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 218

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading

Top 5 Most Recently Viewed Articles

Grand Circle Cruise Line Achieves Top Honors for 2025 Travel

Updated Category News Views 271

Grand Circle Cruise Line Recognized Among the Best Grand Circle Cruise Line (GCCL) recently earned the impressive title of #2 Best River Cruise Line in the Travel + Leisure's 2025 World's Best Awards. This accolade showcases the hard work and dedication of the teams and crew members who make each journey remarkable along Europe’s scenic rivers. Celebrating a Special...

Continue Reading
Lancaster Resources Achieves License Approval for Gold Project Exploration

Updated Category News Views 145

Lancaster Resources Secures Approval for Exploration License Vancouver-based Lancaster Resources Inc. (CSE:LCR) (OTC:LANRF) (FRA:6UF0) is pleased to announce a significant milestone in its gold exploration journey. The company has received confirmation of an Exploration License for the Lake Cargelligo Gold Project from the State of New South Wales. Covering an impressive...

Continue Reading
Future of Vitrectomy Devices: Growth Insights and Trends

Updated Category News Views 93

Understanding the Vitrectomy Devices Market Growth The vitrectomy devices industry has become increasingly vital in treating various eye-related disorders, with significant growth projected in the coming years. By focusing on technological advancements and heightened awareness of eye health, the market is set to expand impressively. According to a recent report, the...

Continue Reading
Exploring RDG Mining's Innovative Cloud Mining Solution

Updated Category News Views 158

Understanding RDG Mining's Latest Offerings In recent times, the popularity of cryptocurrency has surged significantly, with platforms like RDG Mining capitalizing on this trend. RDG Mining is a leading cloud mining service based in the UK that has captured the interest of over 7.5 million users globally, particularly with the rise in various cryptocurrencies, including...

Continue Reading
Pharma Equity Group Updates Its Financial Reporting Strategy

Updated Category News Views 82

Revisions to Financial Reporting and Calendar The board of Pharma Equity Group A/S has recently made the strategic decision to submit only half-yearly financial reports moving forward. This adjustment reflects a shift in focus towards more impactful reporting. As a result, the financial calendar for 2025 has been updated to better align with these new reporting practices....

Continue Reading